Filter
1

Registry for Stage 2 Type 1 Diabetes

for
Type 1 Diabetes
Location: New Haven CT, Manhasset NY, Staten Island NY,
Sponsor: Sanofi

Sex: All

Age: 0+

Code: NCT06481904

Recruiting

Long-Term Outcomes of Teplizumab in Routine Clinical Care

for
Type 1 Diabetes
Location: Syosset NY, New York NY, Atlanta GA, Sandy City UT
Sponsor: Sanofi

Sex: All

Age: 0+

Code: NCT07360080

Recruiting

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

for
Type 1 Diabetes
Location: San Francisco CA
Sponsor: Sanofi

Sex: All

Age: 8+

Code: NCT07260110

Recruiting

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

for
Diabetic Foot Ulcer, DFU, Diabetic Foot Ulcer (DFU),
Location: Monroeville PA
Sponsor: Sequence LifeScience, Inc.

Sex: All

Age: 18+

Code: NCT07086443

Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 1 - 25

Code: NCT07088068

Phase3, Recruiting

Interested in new diabetes mellitus, type 1 trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

for
Type 1 Diabetes Mellitus
Location: Miami FL
Sponsor: Rodolfo Alejandro

Sex: All

Age: 18 - 70

Code: NCT01999361

Recruiting

Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss

for
Type 1 Diabetes Mellitus
Location: Miami FL
Sponsor: Rodolfo Alejandro

Sex: All

Age: 18 - 70+

Code: NCT02000687

Recruiting

Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes

for
Diabetes Mellitus, Metabolic Integrity
Location: Batesville MS
Sponsor: Global Infusion and Aspiration Systems, LLC

Sex: All

Age: 18 - 70+

Code: NCT01023165

Phase3, Recruiting

A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

for
Diabetes Mellitus
Location: California CA
Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All

Age: 18 - 70

Code: NCT02059564

Phase1, Recruiting